About I nem 500 mg Injection
I Nem 500 Injection is a broad-spectrum carbapenem antibiotic containing Imipenem 500 mg and Cilastatin 500 mg. It is used for the treatment of severe and complicated bacterial infections caused by susceptible organisms. The combination helps provide effective antibacterial coverage against a wide range of Gram-positive, Gram-negative, aerobic, and anaerobic bacteria.
I Nem 500 Injection is widely used in hospitals and healthcare facilities for managing serious infections affecting the lungs, urinary tract, abdomen, skin, bloodstream, bones, joints, and other body systems. It is administered intravenously by qualified healthcare professionals.
Grab the potent I-nem 500 mg Injection, a high-grade carbapenem antibiotic crafted for unmatchable results in combating severe and complicated bacterial infections. With a shelf life of 24 months from manufacture, this advance purchase is perfect for traders, exporters, and healthcare providers seeking Ace performance. Each glass vial contains powerful Imipenem (500 mg) and Cilastatin Sodium in a lyophilized powder, designed for IV infusion post-reconstitution. Adhere to the doctor's dosage directions and enjoy markdown offers on wholesale orders. Prescription required.
Advanced Usage and Key Benefits of I-nem 500 mg
I-nem 500 mg Injection is administered as an intravenous infusion after reconstitution with the recommended diluent. Apply this Ace antibiotic strictly under medical supervision for robust defense against severe infections. The injection acts on systemic infections, offering unmatchable therapeutic benefits. Its unique combination ensures potent antibacterial action, reducing microbial resistance and supporting rapid patient recovery. Ensure administration follows your physician's precise guidelines for maximum efficacy and minimal side effects.
Market Presence
Orders for I-nem 500 mg Injection are processed efficiently, with products delivered swiftly to major export markets including South-East Asia, Africa, and the Middle East. The supply network is robust, ensuring the product reaches clients on time. Complimentary samples are available as per the company's sample policy to facilitate product evaluation before large orders. Wholesalers and traders benefit from seamless order processing, making I-nem the preferred choice for global medical supply chains.
We support international procurement requirements for:
- Pharmaceutical importers
- Hospital groups
- Government tenders
- Healthcare institutions
- Medical procurement agencies
- International distributors
- NGO and humanitarian healthcare projects
FAQ's of I-nem 500 mg Injection:
Q: How should I-nem 500 mg Injection be prepared and administered?
A: I-nem 500 mg Injection should be reconstituted with the recommended diluent and administered via intravenous (IV) infusion only, as directed by a healthcare professional.
Q: What are the primary indications for using I-nem 500 mg Injection?
A: This injection is indicated for severe and complicated bacterial infections, including those affecting the lungs, abdomen, gynecological areas, bloodstream (septicemia), and urinary tract.
Q: When can I expect delivery of I-nem 500 mg Injection after placing an order?
A: Orders are processed promptly and delivery timelines vary by location, but most clients in key export markets receive their supply within the stipulated period communicated during order confirmation.
Q: What precautions should be taken during the usage of I-nem 500 mg Injection?
A: Do not use I-nem if you have known hypersensitivity to imipenem, cilastatin, or carbapenem antibiotics. Only administer under medical supervision and as prescribed by your doctor.
Q: Where is I-nem 500 mg Injection manufactured and who can source it?
A: I-nem is manufactured in India and can be sourced by exporters, wholesalers, traders, and suppliers globally.
Q: What is the benefit of choosing I-nem 500 mg Injection for severe infections?
A: I-nem 500 mg Injection provides a potent and broad-spectrum antibacterial effect, making it highly effective for treating complex and resistant bacterial infections.